Supplementary Table 2.

Estimated Probability of Survival 50 Days After the Symptoms, Stratified by Age (2 Categories), Main Immunosuppressant and Chronic Kidney Disease

Age	Main Immunosuppressant	Chronic kidney diseasea	Patients (n)	Probability of survival at 50 days (95% CI)
≤ 70 y	TAC	No	113	0.89 (0.82–0.94)
		Yes	16	0.86 (0.55–0.96)
	CsA/mTOR/MMF/other	No	39	0.90 (0.75–0.96)
		Yes	13	0.54 (0.25–0.76)
>70 y	TAC	No	16	0.75 (0.46–0.90)
		Yes	10	0.77 (0.34–0.94)
	CsA/mTOR/MMF/other	No	20	0.50 (0.27–0.69)
		Yes	7	0.29 (0.01–0.69)

NOTE. Estimates are based on Kaplan-Meier curves.

mTOR, mammalian target of rapamycin inhibitor

^aPlasma creatinine >2 mg/dL.